期刊
ORAL ONCOLOGY
卷 106, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.oraloncology.2020.104723
关键词
Head and neck squamous cell carcinoma; Tumor-associated macrophages; Immunotherapy; Immuno-oncology
资金
- Youth Grant of the Science and Technology Department of Sichuan Province, China [2017JQ0028]
- Innovative Research Team Program of Sichuan Province
In head and neck squamous cell carcinoma (HNSCC), tumor-associated macrophages (TAMs) are associated with a poorer prognosis. TAMs, derived from inflammatory monocyte, play a critical role in regulating tumor progression. Generally, TAMs promote tumor progression and suppress immune response via both innate and adaptive immune mechanisms. However, as the double-blade sword, TAMs retain the potential pro-inflammatory ability to inhibit tumor progression. By depleting the immunosuppressive function or evoking antitumor ability, therapeutic strategies targeting TAMs show promising preclinical and clinical effects. Now, macrophage-centered therapeutic approaches are entering the clinical arena. In this review, we discuss the immunosuppressive role of TAMs in the tumor microenvironment and the therapeutic approaches targeting macrophages which offer promise in improving HNSCC outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据